Michael J. Pederson is President & VP at ABBOTT LABORATORIES (ABT). They have made 5 open-market trades across 1 company since 2018, most recently 2023-02-28.
CIK 0001712233
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABT | 63,156 | $7.3M |
Shares reported on the most recent Form 4, priced at the 2023-03-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABT | SELL | 2021-09-08 | 2021-09-10 | $129.05 | $5.9M | -3.9% | -9.9% | +2.2% |
| ABT | SELL | 2020-07-21 | 2020-07-23 | $98.00 | $2.3M | -0.3% | +1.2% | +5.7% |
| ABT | SELL | 2019-08-09 | 2019-08-13 | $86.39 | $4.0M | -4.6% | -0.8% | -2.5% |
| ABT | SELL | 2018-07-23 | 2018-07-24 | $63.46 | $118K | +1.7% | +2.6% | +6.8% |
| ABT | SELL | 2018-02-20 | 2018-02-21 | $59.29 | $27K | +2.0% | +0.5% | +3.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.